Infant Infection With Respiratory Syncytial Virus Genotypes and Subsequent Childhood Asthma Risk Authors: Christian Rosas-Salazar, Tebeb Gebretsadik, James D Chappell, R Stokes Peebles, William D Dupont, Meghan H Shilts, Samadhan J Jadhao, Larry J Anderson, Suman R Das, Tina V Hartert Published: 2026 ABSTRACT AbstractOur objective was to test the hypothesis that respiratory syncytial virus (RSV) infection during infancy with genotypes containing previously reported G gene sequence duplications (Gdups) is associated with an increased risk of childhood asthma. In a population-based, prospective, birth cohort of healthy, term children, we found that children with RSV-A Gdup+ (adjusted odds ratio [aOR] = 2.00, 95%CI = 1.15–3.47) and RSV-B Gdup + (aOR = 1.78, 95%CI = 1.01–3.11) infections during infancy had higher odds of 5-year current asthma than those without RSV infection during infancy. These findings are proof-of-concept evidence that RSV genetic variation is associated with variable childhood asthma risk.Keywords: asthma, children, G gene, genotype, respiratory syncytial virus The body of research suggests that RSV infection during infancy is associated with an increased risk of childhood asthma [1]. Yet, a minority of infants infected with RSV will ultimately develop childhood asthma, suggesting that there are viral, host, and/or environmental factors that contribute to variable susceptibility to long-term health outcomes following RSV infection in the first year of life. Because RSV G gene mutations have been postulated to impact the pathogenesis of this respiratory virus [2], we hypothesized that RSV infection during infancy with genotypes containing previously reported G gene sequence duplications (Gdups) is associated with an increased risk of childhood asthma. To test this hypothesis, we leveraged a population-based, prospective, birth cohort of healthy, term children with close epidemiologic surveillance during each child's first RSV season, RSV whole-genome sequencing data from nasal washes collected during RSV infection during infancy, and serial follow-up for childhood asthma development. METHODS Full details are available in the Supplementary Methods. Overview of the Study Design The Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE) recruited 1946 children near birth [1, 3]. Follow-up for the ascertainment of childhood asthma has been conducted annually. The Institutional Review Board of Vanderbilt University approved this study and one parent provided informed consent for their and their child's participation. Determination of RSV Infection During Infancy and RSV Whole-Genome Sequencing Passive and active surveillance were performed during each child's first RSV season [1, 3]. If a child met pre-specified criteria for an acute respiratory infection, we collected a nasal wash that was used to detect RSV by reverse transcription-quantitative PCR (RT-qPCR). If the nasal wash was positive for RSV by RT-qPCR, we performed RSV whole-genome sequencing, genome assembly, and genotype assignment [4, 5]. In addition, we measured RSV serum antibody titers at age 1 year [1]. Children were classified as infected versus not infected with RSV during infancy based on the results of the RSV RT-qPCR and 1-year RSV serology as described elsewhere [1]. Eligibility Criteria for the Current Study and Study Population For the current study and based on our hypothesis, we included children enrolled in INSPIRE (1) with RSV infection during infancy and available RSV whole genome-sequencing data, and (2) without RSV infection during infancy to serve as an RSV-negative comparator group (Supplementary Figure 1). Genotype of the RSV Infection During Infancy The genotype of the RSV infection during infancy was categorized using the available RSV whole genome-sequencing data into mutually exclusive groups based on the antigenic subgroup (RSV-A vs RSV-B) and the presence of previously reported Gdups (yes vs no [hereinafter termed Gdup+ and Gdup–, respectively]) [2, 4]. Definition of Outcomes Our primary, secondary, and exploratory outcomes were 5-year current asthma, the respiratory severity score (RSS), and the 5-year childhood asthma phenotype (allergic or nonallergic), respectively, as defined in the Supplementary Methods [1]. Statistical Analyses To examine the associations of interest, we used unadjusted and adjusted linear regression, binary logistic regression, or multinomial logistic regression. The adjusted models included the child's sex, race and ethnicity, maternal asthma, ever breastfeeding, daycare attendance during infancy, and (for the outcome of the RSS only) age at RSV infection as base covariates, which were selected a priori based on published literature and by creating a causal directed acyclic graph (Supplementary Figure 2). For our primary outcome, we also (1) built supplementary models by either replacing base covariates with proxy covariates or by including additional covariates, and (2) tested for interactions between genotype of the RSV infection and the child's sex, race and ethnicity, and maternal asthma in separate models while adjusting for base covariates. A two-sided P-value <.05 was considered statistically significant. Statistical analyses were performed using R. RESULTS One thousand one hundred and two (56.63%) of the 1946 eligible children met eligibility criteria for the current study, including 305 (27.68%) children with RSV infection during infancy (Supplementary Figure 1). The circulation of the different RSV genotypes varied by RSV season (Supplementary Figure 3). There were no RSV infections during infancy with the RSV-B Gdup– genotype. Children with RSV-A Gdup– infection during infancy were more likely to be older at enrollment, male, enrolled in 2012, and to have attended daycare during infancy than children in other groups (Table 1). Children with RSV-A Gdup+ infection during infancy were more likely to have lived with another child aged <6 years at home during infancy than children in other groups (Table 1). The baseline characteristics of children who were included and not included in the current study are shown in Supplementary Table 1. Table 1.Baseline characteristics of children included in the current study by genotype of the RSV infection during infancy.a,bNo RSV Infection During Infancy (n = 797 [72.32%])RSV Infection During Infancy With The RSV-A Gdup+ Genotype (n = 124 [11.25%)RSV Infection During Infancy With The RSV-A Gdup− Genotype (n = 60 [5.44%])RSV Infection During Infancy With The RSV-B Gdup+ Genotype (n = 121 [10.98%])All (n = 1102)Age at enrollment (days)51 (15, 75)60 (16, 82)63 (28, 111)37 (15, 70)c53 (15, 76)Age at RSV infection (months)—4 (2, 5)5 (3, 6)4 (2, 5)—Female sex391 (49%)60 (48%)17 (28%)59 (49%)c527 (48%)Race and ethnicity Black non-Hispanic116 (15%)20 (16%)6 (10%)19 (16%)161 (15%) White non-Hispanic551 (69%)84 (68%)42 (70%)86 (71%)763 (69%) Hispanic65 (8%)12 (10%)7 (12%)7 (6%)91 (8%) Other65 (8%)8 (6%)5 (8%)9 (7%)87 (8%)Enrollment year (first RSV season) 2012 (2012–2013)340 (43%)81 (65%)58 (97%)22 (18%)c501 (45%) 2013 (2013–2014)457 (57%)43 (35%)2 (3%)99 (82%)601 (55%)Gestational age (weeks)39 (39, 40)39 (39, 40)39 (39, 40)39 (38, 40)39 (39, 40)Birth weight (grams)3405 (3,120, 3717)3433 (3,121, 3717)3575 (3,299, 3866)3405 (3,125, 3710)3433 (3,121, 3746)Birth by cesarean section233 (29%)37 (30%)27 (45%)33 (27%)330 (30%)Ever breastfeeding653 (82%)91 (75%)51 (88%)93 (80%)888 (81%)Daycare attendance during infancy234 (29%)45 (38%)28 (52%)54 (47%)c361 (33%)Presence of another child aged <6 years at home during infancy353 (44%)79 (64%)34 (57%)66 (55%)c532 (48%)Maternal asthma160 (20%)21 (17%)13 (22%)23 (19%)217 (20%)Exposure to secondhand smoke in utero or during early infancy162 (20%)33 (27%)8 (13%)29 (24%)232 (21%)Type of insurance Federal or state402 (50%)61 (49%)24 (40%)65 (54%)552 (50%) Private384 (48%)61 (49%)34 (57%)56 (46%)535 (49%) Other or unknown11 (1%)2 (2%)2 (3%)0 (0%)15 (1%)Socioeconomic status theme of the social vulnerability index0.54 (0.36, 0.74)0.55 (0.31, 0.72)0.55 (0.35, 0.71)0.49 (0.32, 0.68)0.53 (0.34, 0.72)Abbreviations: Gdup, G gene sequence duplication; RSV, Respiratory syncytial virus. aData presented as median (interquartile range) for continuous variables or frequencies (%) for categorical variables. bStatistical analyses included children with complete data. c P < .05 for the comparison between the groups using Kruskal-Wallis or Pearson chi-squared tests as appropriate. Baseline characteristics of children included in the current study by genotype of the RSV infection during infancy.a,b Abbreviations: Gdup, G gene sequence duplication; RSV, Respiratory syncytial virus. aData presented as median (interquartile range) for continuous variables or frequencies (%) for categorical variables. bStatistical analyses included children with complete data. c P < .05 for the comparison between the groups using Kruskal-Wallis or Pearson chi-squared tests as appropriate. The 5-year follow-up visit rate for children included in the current study was 797/1102 (72.32%). The proportion of 5-year current asthma was 22/85 (25.88%) in children with RSV-A Gdup+ infection during infancy, 21/87 (24.14%) in children with RSV-B Gdup+ infection during infancy, 6/38 (15.79%) in children with RSV-A Gdup− infection during infancy, and 91/587 (15.50%) in children without RSV infection during infancy (P = .04). In adjusted models including base covariates, there was a significant association of genotype of the RSV infection during infancy with the odds of 5-year current asthma (overall P = .03). Children with RSV-A Gdup+ and RSV-B Gdup+ infections during infancy had higher odds of 5-year current asthma than those without RSV infection during infancy, whereas those with RSV-A Gdup− infection during infancy did not (Figure 1 and Supplementary Table 2). In supplementary models, we obtained overall similar results when replacing base covariates with proxy covariates or when including additional covariates. However, only the estimates of the association among children with RSV-A Gdup+ infection during infancy remained consistent across all supplementary models (Supplementary Table 2). The association of genotype of the RSV infection during infancy and 5-year current asthma was not modified by the child's sex, race and ethnicity, or maternal asthma (P > .05 for all interaction terms). The association of genotype of the RSV infection during infancy with 5-year current asthma. The plot estimates were obtained from a binary logistic regression model that included the child's sex, race and ethnicity, maternal asthma, ever breastfeeding, and daycare attendance during infancy as covariates. The aOR (squares) and corresponding 95%CI (adjacent lines) for each genotype of the RSV infection during infancy are shown. Children without RSV infection during infancy were included as the reference group for the model. Abbreviations: aOR, Adjusted odds ratio; CI, Confidence interval; Gdup, G gene sequence duplication; RSV, Respiratory syncytial virus. The median (interquartile range) RSS was 3 (2–4) in children with RSV-A Gdup+ infection during infancy, 3 (2–4) in children with RSV-B Gdup+ infection during infancy, and 2 (2–4) in children with RSV-A Gdup− infection during infancy (P = .4). There was no association of genotype of the RSV infection during infancy with the RSS in adjusted models including base covariates (Supplementary Table 3). The proportion of 5-year current asthma phenotypes differed by genotype of the RSV infection during infancy (P = .006). In adjusted models including base covariates, children with RSV-A Gdup+ infection during infancy had higher odds of 5-year current nonallergic asthma than those without RSV infection during infancy, whereas the odds of 5-year current nonallergic asthma were not increased among children with RSV-B Gdup+ or RSV-A Gdup− infection during infancy. In contrast, the odds of 5-year current allergic asthma were not increased among children with RSV-A Gdup+, RSV-B Gdup+, or RSV-A Gdup− (Supplementary Table 4). DISCUSSION In our study, we found that children with RSV-A Gdup+ infection during infancy had approximately 2-fold increased odds of childhood asthma than those with RSV infection during infancy with genotypes lacking previously reported Gdups or those without RSV infection during infancy. Our findings are important as they (1) are proof-of-concept evidence that RSV genetic variation is associated with variable childhood asthma risk, and (2) may partly explain the difference in asthma susceptibility among children with RSV infection during infancy. To our knowledge, this the first study to show that individual RSV genotypes can differentially impact the risk of childhood asthma. In line with our prior studies, we found that multiple RSV genotypes were co-circulating during the 2012–2014 RSV seasons in middle Tennessee [4, 6]. Our results of an absence of circulating RSV-B Gdup− genotypes is expected, as the Gdup became fixed across RSV-B lineages after 1999 [4]. The Gdup was not reported among RSV-A lineages until 2010, but the insertion is present as an exact, tandem, in-frame duplication of the same region in both RSV-A and RSV-B, possibly because the Gdup provides some type of selective advantage to the two antigenic subgroups and helps evade herd immunity [2, 4]. Because of our study's observational design, we can only hypothesize the mechanisms through which RSV infection during infancy with genotypes containing previously reported Gdups could confer a higher risk of childhood asthma. The G glycoprotein is the principal viral attachment protein and genetic variations in the G gene have been implicated in RSV pathogenesis in numerous pre-clinical and some human studies. For example, experiments in murine models have shown that administration of anti-G glycoprotein antibodies prior to and/or after RSV infection leads to decreased viral titers, airway inflammation, weight loss, airway mucous production, work of breathing, and/or airway hyper responsiveness [2, 7–9]. The results of in vitro studies also suggest that the G glycoprotein has wide ranging effects on the host's innate and adaptive immune responses [2]. In regard to the specific functional effects of Gdups, one study that generated recombinant viruses demonstrated that RSV-B Gdup + genotypes can more efficiently attach to the host's cell surface and better replicate than RSV-B Gdup− genotypes [10]. Similarly, a study that generated lentiviral pseudo particles harboring G glycoproteins from RSV-A Gdup+ and RSV-A Gdup− genotypes indicated that the Gdup has a higher infectivity and may offer a selective advantage [11]. Likewise, we previously identified unique G gene variants associated with RSV persistence and an increased acute disease severity among children infected with RSV during infancy [5, 12]. On the other hand, studies examining whether Gdups impact the acute disease severity of the RSV infection during infancy have yielded conflicting results [13, 14]. Our findings suggest that children with RSV-A Gdup+ infection during infancy are at a higher risk of developing a nonallergic childhood asthma phenotype. Because of the small sample sizes for some subgroups, these statistical analyses should be considered exploratory. Nonetheless, these results are consistent with our previous studies showing an increased proportion of nonallergic childhood asthma phenotypes among children with RSV infection during infancy [1]. Our study has multiple strengths, including (1) the novel a priori hypothesis, (2) the inclusion of children without RSV infection during infancy as the reference group, whereas most studies examining the association of RSV infection during infancy with childhood asthma have not had a true control group, and (3) the collection of samples during a period when both RSV-A Gdup+ and RSV-A Gdup− genotypes were co-circulating in our region and before the RSV-A Gdup+ genotype became the predominant circulating strain worldwide [4, 6]. We should also acknowledge certain limitations. First, we cannot exclude misclassification of children categorized as not infected with RSV during infancy. However, the serologic method we used to determine the RSV-negative comparator group performs well compared with other similar laboratory assays [15]. Second, it is difficult to ascertain childhood asthma in younger children as they frequently cannot perform objective testing. It is also possible that individual RSV genotypes could differentially impact childhood asthma phenotypes not considered in the current study (eg, early-transient vs persistent wheeze), which will need to be assessed in future studies. Third, we used antigenic subgroups and the presence of previously reported Gdups to categorize RSV genotypes based on our hypothesis and because these represent the major new viral strains emerging over the last several decades [2, 4]. However, it is conceivable that the distinct risks of childhood asthma among RSV genotypes could be attributed to other genetic variations not considered in the current study. Last, unmeasured confounding could not be completely ruled out from influencing our results. In summary, our findings reveal that RSV infection during infancy with genotypes containing previously reported Gdups is associated with an increased risk of childhood asthma. While RSV genotypes lacking previously reported Gdups are no longer circulating, our findings emphasize the need for continuing surveillance of RSV evolutionary dynamics. This is particularly important in the context of the recently introduced RSV prevention products, which are highly effective in reducing acute disease severity, but do not impact the risk of RSV infection during infancy and could lead to the emergence of more pathogenic RSV genotypes. Furthermore, our results underscore the importance of considering individual RSV genotypes when examining the association of RSV infection during infancy with long-term pulmonary disease morbidity. Supplementary Material Notes Acknowledgments. None declared. Authors’ Contributions. C. R-. S., T. G., W. D. D., R. S. P., and T. V. H. contributed to the conception of the study and/or the study design. R. S. P., L. J. A., and T. V. H. obtained the research funding supporting this study. J. D. C., M. H. S., S. J. J., L. J. A., and S. R. D. contributed to the sample processing and laboratory assays. C. R-. S. and T. G. contributed to the statistical analyses. All authors contributed to the interpretation of the data. C. R-. S., T. G., and T. V. H. wrote the initial version of the manuscript. All authors reviewed this initial version, revised it critically for important intellectual content, and approved the final version. No independent medical writers or editors were used. C. R-. S., T. G., and T. V. H. directly accessed and verified the underlying data reported in the manuscript. All authors have full access to all the data in the study and accept responsibility to submit for publication. They also agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Financial support. This work was supported in whole or in part with funds from the National Institute of Allergy and Infectious Diseases (under award numbers U19AI095227, UG3OD023282, K24AI77930, and U19AI110819); the Vanderbilt Institute for Clinical and Translational Research (grant support from the National Center for Advancing Translational Sciences under award number UL1TR000445); and the National Heart, Lung, and Blood Institute (under award number K23HL148638). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. Data availability. The RSV whole-genome sequences used for the current study were previously submitted to GenBank under Bioproject IDs PRJNA241108, PRJNA225816, and PRJNA267583, with accession numbers KJ672424.1 to KX894807.1 (KM042382.1, KM042387.1, and KU950597.1 are partial sequences). Otherwise, fully de-identified individual participant data that underlie the results reported in this manuscript will be shared with other researchers beginning 12 months and ending 36 months following its publication, only for the purpose of conducting systematic reviews with meta-analyses, and upon approval by the corresponding author. For this, researchers requesting the data will need to have their study approved by an independent review committee (such as an institutional review board) and directly contact the corresponding author. Notice of Prior Presentation: Some of this study's results were presented as an abstract in May 2025 at the 2025 American Thoracic Society International Conference (San Francisco, California, United States of America). Contributor Information Christian Rosas-Salazar, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Tebeb Gebretsadik, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. James D Chappell, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. R Stokes Peebles, Jr., Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA William D Dupont, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Meghan H Shilts, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Samadhan J Jadhao, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA. Larry J Anderson, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA. Suman R Das, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Tina V Hartert, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Supplementary Data Supplementary materials are available at The Journal of Infectious Diseases online (http://jid.oxfordjournals.org/). Supplementary materials consist of data provided by the author that are published to benefit the reader. The posted materials are not copyedited. The contents of all supplementary data are the sole responsibility of the authors. Questions or messages regarding errors should be addressed to the author. References Associated Data Supplementary Materials